| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Clinical consensus statement: Establishing the roles of locoregional and systemic therapies for the treatment of intermediate-stage hepatocellular carcinoma in Canada
|
Wong, Jason K.
|
|
|
115 |
C |
p.
|
artikel
|
| 2 |
Clinical development of WEE1 inhibitors in gynecological cancers: A systematic review
|
Schutte, Tim
|
|
|
115 |
C |
p.
|
artikel
|
| 3 |
Comparison of HER2-zero and HER2-low in terms of clinicopathological factors and survival in early-stage breast cancer: A systematic review and meta-analysis
|
Ergun, Yakup
|
|
|
115 |
C |
p.
|
artikel
|
| 4 |
Corrigendum to “SELNET clinical practice guidelines for soft tissue sarcoma and GIST” [Cancer Treat. Rev. 102 (2021) 102312]
|
Blay, J.Y.
|
|
|
115 |
C |
p.
|
artikel
|
| 5 |
Editorial Board
|
|
|
|
115 |
C |
p.
|
artikel
|
| 6 |
Efficacy and safety of antiemetic regimens for highly emetogenic chemotherapy-induced nausea and vomiting: A systematic review and network meta-analysis
|
Filetti, Marco
|
|
|
115 |
C |
p.
|
artikel
|
| 7 |
Epidemiology, clinical outcomes, and unmet needs of patients with human epidermal growth factor receptor 2-positive breast cancer and brain metastases: A systematic literature review
|
Müller, Volkmar
|
|
|
115 |
C |
p.
|
artikel
|
| 8 |
European expert panel consensus on the clinical management of BRAFV600E
-mutant metastatic colorectal cancer
|
Martinelli, Erika
|
|
|
115 |
C |
p.
|
artikel
|
| 9 |
Incorporating radioligand therapy in clinical practice in the United States for patients with prostate cancer
|
Calais, Jeremie
|
|
|
115 |
C |
p.
|
artikel
|
| 10 |
Is tebentafusp superior to combined immune checkpoint blockade and other systemic treatments in metastatic uveal melanoma? A comparative efficacy analysis with population adjustment
|
Petzold, Anne
|
|
|
115 |
C |
p.
|
artikel
|
| 11 |
nmCRPC, a look in the continuous care of prostate cancer patients: state of art and future perspectives
|
Berruti, Alfredo
|
|
|
115 |
C |
p.
|
artikel
|
| 12 |
Optimizing treatment for HER2-positive HR-positive breast cancer
|
Debien, Veronique
|
|
|
115 |
C |
p.
|
artikel
|
| 13 |
Post nephrectomy management of localized renal cell carcinoma. From risk stratification to therapeutic evidence in an evolving clinical scenario
|
Ciccarese, Chiara
|
|
|
115 |
C |
p.
|
artikel
|
| 14 |
Role of FGFR3 in bladder cancer: Treatment landscape and future challenges
|
Ascione, Claudia Maria
|
|
|
115 |
C |
p.
|
artikel
|
Tijdschrift beschrijving